MT925

N/A

Report date: 2024/11/21 16:54:10

Base Information

Drug NameMT925

Drug Alias NameMT-925

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionAnti-CD3

TargetsT cell surface glycoprotein CD3

Therapy Area/IndicationsDiabetes Mellitus, Type 1

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMedytox Inc

China Registration ClassN/A

Active CompaniesMedytox Inc

Inactive CompaniesN/A

Active IndicationsDiabetes Mellitus, Type 1

Inactive IndicationsN/A

ATC CodeN/A